Founder of Freeline Therapeutics Holdings Plc, Novalgen Ltd. and Freeline Therapeutics Ltd., Amit Chunilal Nathwani is a British entrepreneur who currently occupies the position of Director & Chief Scientific Officer at Freeline Therapeutics Ltd. and Chief Executive Officer & Director at Novalgen Ltd. Dr. Nathwani is also on the board of Freeline Therapeutics Holdings Plc and Professor at University College London and Director-Katharine Dormandy Hemophilia Centre at Royal Free Hospital Medical School.

He received a doctorate from The Open University and an undergraduate degree from the University of Aberdeen.